---
$id: https://graph.org.ai/products/commodity/51351508
$type: Product
source: UNSPSC
code: "51351508"
title: "Medrogestone"
class: "51351500"
classTitle: "Estrogen, progestin, or internal contraceptive pregnanes"
family: "51350000"
familyTitle: "Estrogens and progestins and internal contraceptives"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Medrogestone

**UNSPSC Code**: 51351508
**Class**: [Estrogen, progestin, or internal contraceptive pregnanes](Estrogen, progestin, or internal contraceptive pregnanes.mdx)
**Family**: [Estrogens and progestins and internal contraceptives](../Estrogens and progestins and internal contraceptives.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a therapeutic progestin with the molecular formula C23H32O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 077DN93G5B, chemically known as 6,17-dimethylpregna-4,6-diene-3,20-dione but generally known as medrogestone, which bears US NIH Compound Identifier 13790. European Medicines Agency schedules Medrogestone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08696MIG. The term MEDROGESTONE is an International Non-Proprietary Name. World Health Organization schedules medrogestone in its Anatomical Therapeutic Chemical (ATC) Classification. MEDROGESTONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule medrogestone under HS 29372300 and SITC 54153. As of Q4 2014, MEDROGESTONE remains the US FDA Preferred Term for this commodity. Medrogestone bears US NLM identifiers UMLS ID C0025145 and NCI Concept Code C90970. SMILES: O=C(C1(C2(C(C3C(CC2)C2(C(=CC(=O)CC2)C(=C3)C)C)CC1)C)C)C.

